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The incidence of contralateral breast cancer is high and constant with 
age, around 5/1,000 women who had a primary breast cancer. For other 
neoplasms, the pattern of incidence of second primary neoplasms with 
age is less known, particularly since for only a few neoplasms the site of 
origin is not totally removed, and hence remains at risk of a second 
primary. Using the dataset from the cancer Registry of the Swiss Canton 
of Vaud, we show that the incidence of second neoplasms is constant 
with age also after oral and pharyngeal, colorectal cancers, cutaneous 
malignant melanoma (CMM) and basal cell carcinoma. The incidence of 
first primary oral and pharyngeal cancer increased 20-fold between age 
30-39 and 70-89, whereas the incidence of second neoplasms did not 
increase with age.  Rates of second colorectal cancer remained relatively 
constant with age, between 2.5/1,000 at age 40-59 and 3.8/1,000 at 70 
and over. Likewise, for CMM, the age-specific incidence rates of second 
primary CMM did not vary with age, ranging between 1 and 2.5/1,000 in 
various subsequent age groups.  The pattern of incidence for second 
BCC was similar, with no clear rise with age. Interpretation and possible 
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